What You Need to Know About Paxlovid, Pfizer’s COVID-19 Pill
On Wednesday, the Food and Drug Administration authorized Paxlovid, the first prescription antiviral pill specifically designed to treat mild to moderate cases of COVID-19 in at-risk patients.
You probably have lot of questions about Paxlovid and fair. Here’s everything you need to know about thePaxlovid has two main ingredients—nirmatrelvir and ritonavir. Together, these ingredients work to inhibit a protein in SARS-CoV-2, the virus that causes COVID-19. Nirmatrelvir specifically stops the virus from replicating and ritonavir works to slow the breakdown of nirmatrelvir to help it stay in the body for longer periods of time at higher concentrations.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA authorizes first Covid pill, from Pfizer, for emergency useBREAKING: FDA authorizes first Covid-19 antiviral pill in the US to protect against severe disease.
Read more »
FDA authorizes first pill to treat Covid-19The FDA authorizes the first pill to treat Covid-19. Pfizer's Paxlovid is meant to be taken at home before people are sick enough to be hospitalized.
Read more »
FDA OKs Emergency Use of Merck Pill for COVID-19The FDA has granted emergency use authorization to Merck’s antiviral drug to treat adults with mild to moderate COVID-19 who are at risk for severe disease.
Read more »
Newly authorized Covid pills won't change course of pandemic right awayWith two antiviral pills, from Pfizer and Merck, now cleared to treat Covid-19, many health experts see a shift in the fight against the virus, but not right away.
Read more »
FDA Authorizes Pfizer Antiviral Pill for COVID-19The FDA was also expected to authorize an antiviral pill from Merck, but as of Wednesday afternoon, only Pfizer's had been authorized for use.
Read more »